Clinical trials white paper – Enhancing Melbourne’s Clinical Trials Reputation
Posted: 30 October 2025 BioMelbourne Network is proud to release its latest white paper, Enhancing Melbourne’s Clinical Trials Reputation, shaped by insights from key stakeholders who participated in its Clinical Trials Focus Group earlier this year. This paper…
BioMelbourne Network’s Modernising clinical trials BioSymposium explores execution, access and impact for new directions in the clinical trials sector
Posted: 17 September 2025 With the theatrette at Melbourne Museum filled with around 150 curious and eager-to-learn attendees generating lively discussions, the second BioMelbourne Network BioSymposium of 2025, ‘Modernising clinical trials: Execution, access and impact’, brought the sector…
Nominations open for the prestigious BioMelbourne Network 2026 Women in Leadership Awards
Posted: 17 September 2025 BioMelbourne Network, the peak industry body for Victoria’s health technologies sector, today announced the launch of the prestigious Women in Leadership Awards (WILA), now in their 11th year. The Awards recognise and champion…
Trade Mission with Singapore 2022
Posted: 29 August 2022 See a full overview of Trade Mission with Singapore 2022 here. Are you a service provider that wants to access foreign markets? Do you want to identify opportunities, understand the network and connect but…
Trade Mission between Singapore & Victoria 2022
Do you want to understand and access the Victorian (Australia) health and medtech ecosystem to support with your product development? But unsure how or where to begin? Find the right partners in Victoria to support you on your…
Healthtech Industry – Freight and Logistics Update
Last updated: 2 March 2022 Following on from the development of our Industry Report: Assessing pandemic impact on freight and logistics for the Victorian Healthtech Industry, BioMelbourne Network continues to maintain close contact with the Victorian Government and…
Industry Report: Assessing pandemic impact on freight and logistics for the Victorian Healthtech Industry
Posted: 3 November 2021 The COVID-19 pandemic has created significant freight and logistics challenges for the Victorian Healthtech Industry. Global Victoria in partnership with BioMelbourne Network conducted an industry review of the Healthtech Industry to identify key issues…
Joint Statement of support for an Australian Patent Box
Posted 15 September 2021 See BioMelbourne Network’s submission in response to the Australian Patent Box See Joint Statement on Patent Box Australia’s health innovators support the introduction of a Patent Box, and we welcome this initiative by the…
R&D Tax Incentive – Federal Budget (October 2021)
8 October 2020 As provided to BioMelbourne Network Members in Insider, 8 October 2020. The following is a summary of the R&D Tax Incentive. Overall the news is good with the Federal Government enhancing some aspects of the…
Updates: Senate Hearing for R&D Tax Incentive Bill (July – September 2020)
3 September 2020 A report was released today from the Senate Select Committee on Financial Technology and Regulatory Technology, chaired by Senator Andrew Bragg. This Committee was reviewing tax, regulation, capital and funding, skills and talent, and culture,…
Victoria’s health industry welcomes Andrews government
30 November 2018 On behalf of its members, BioMelbourne Network congratulates the Hon Daniel Andrews MP and the Victorian Labor party on their re-election at the 2018 state election. BioMelbourne Network CEO Dr Krystal Evans welcomes the opportunity…
2018 state election priorities
Health industry priorities for Victoria Victoria is the state that will change the future of health. The health industry is the industrial sector that encompasses biotechnology, medical technology, pharmaceuticals and digital healthcare that enables research and development as…
